Vadodara-headquartered Sudeep Pharma has initiated steps toward entering India’s capital markets, filing its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). The proposed initial public offering (IPO) will consist of a fresh issue worth ₹95 crore alongside an offer for sale (OFS) of over 1 crore shares by the promoter group.